096530 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Seegene, Inc. engages in the manufacture and distribution of molecular diagnostics and reagents. Its diagnostic services include respiratory pathogen, gastrointestinal pathogen, sexually transmitted infections, human papillomavirus, tuberculosis, sepsis, meningitis, and pathogen. The company was founded by Jong-Yoon Cheon on September 16, 2000 and is headquartered in Seoul, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
096530 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company